Have been working on a presentation on Ajanta Pharma, 2010-2017 was a 25% sales growth period with massive margin expansion leading to stock being a 7

Have been working on a presentation on Ajanta Pharma, 2010-2017 was a 25% sales growth period with massive margin expansion leading to stock being a 7